Non-exec director at drug discovery firm e-Therapeutics plc (LON:ETX) Professor Trevor Jones has bought shares in the company instead of taking part of his fees.
The group said he subscribed for 36,917 new shares at 7.45p each worth around £2,750.
In October, Professor Jones entered into a binding contractual arrangement where he agreed, with effect from October 1 last year to invest 50% of his annual non-executive director fees net of tax in new e-Therapeutics' stock.
He will now be interested in around 107,497 shares, or around 0.04% of the capital.